[AKRO] QoQ Quarter Result on 30-Jun-2018 [#Q2]

Stock
[AKRO] Akero Therapeutics, Inc.
Announcement Date
30-Jun-2018
Financial Year
2018
Quarter
30-Jun-2018 [#Q2]
Profit Trend
QoQ- -1,960.10%
YoY-
Quarter Report
AKRO's Result
AKRO's Financial Summary
View:
Show?
Quarter Result
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -7,228 -5,362 -61,472 -11,148 -8,673 -421 -960 285.57%
Tax -7,609 -5,362 -2,968 0 -8,662 -421 0 -
NP -7,228 -5,362 -61,472 -11,148 -8,673 -421 -1,026 268.80%
Tax Rate - - - - - - - -
Total Cost 7,228 5,362 61,472 11,148 8,673 421 1,026 268.80%
Ratio Analysis
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
EPS -2.21 -0.20 -2.90 -0.53 -0.41 -0.02 -4.54 -38.20%
EPS Diluted -2.21 -0.20 -2.90 -0.53 -0.41 -0.02 -4.53 -38.10%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.